Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
May 01 04:00PM ET
17.70
Dollar change
0.00
Percentage change
0.00
%
Index- P/E37.32 EPS (ttm)0.47 Insider Own17.33% Shs Outstand9.42M Perf Week2.02%
Market Cap166.91M Forward P/E17.70 EPS next Y1.00 Insider Trans0.08% Shs Float7.79M Perf Month37.85%
Income4.60M PEG1.87 EPS next Q0.24 Inst Own33.42% Short Float0.27% Perf Quarter36.79%
Sales82.70M P/S2.02 EPS this Y188.89% Inst Trans0.64% Short Ratio0.95 Perf Half Y41.04%
Book/sh7.25 P/B2.44 EPS next Y28.21% ROA5.30% Short Interest0.02M Perf Year55.13%
Cash/sh0.51 P/C34.49 EPS next 5Y20.00% ROE6.90% 52W Range10.08 - 17.76 Perf YTD50.13%
Dividend Est.- P/FCF27.10 EPS past 5Y-15.93% ROI6.71% 52W High-0.34% Beta0.63
Dividend TTM0.35 (1.98%) Quick Ratio1.86 Sales past 5Y10.29% Gross Margin37.27% 52W Low75.60% ATR (14)0.81
Dividend Ex-DateApr 30, 2024 Current Ratio2.79 EPS Y/Y TTM76.77% Oper. Margin-4.55% RSI (14)80.42 Volatility5.92% 6.09%
Employees224 Debt/Eq0.06 Sales Y/Y TTM6.80% Profit Margin5.56% Recom1.00 Target Price20.00
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q314.69% Payout93.21% Rel Volume2.22 Prev Close17.70
Sales Surprise-1.69% EPS Surprise5.88% Sales Q/Q14.08% EarningsApr 11 BMO Avg Volume21.99K Price17.70
SMA2019.98% SMA5025.14% SMA20037.81% Trades Volume48,827 Change0.00%
Date Action Analyst Rating Change Price Target Change
Aug-18-09Initiated Next Generation Buy $15
Apr-17-24 12:45PM
08:00AM
Apr-16-24 08:50AM
08:44AM
Apr-12-24 03:01AM
12:02AM Loading…
12:02AM
Apr-11-24 09:10AM
08:07AM
08:00AM
Apr-04-24 08:00AM
Mar-22-24 05:06AM
Mar-06-24 12:12AM
Jan-17-24 08:03AM
Jan-12-24 08:15AM
Jan-11-24 11:09PM
03:03PM Loading…
03:03PM
09:15AM
08:39AM
08:09AM
08:00AM
Jan-04-24 08:00AM
Nov-22-23 07:26AM
12:42AM
Nov-21-23 09:18AM
08:18AM
08:02AM
Nov-15-23 08:00AM
Oct-30-23 06:05PM
Oct-18-23 07:00AM
Aug-10-23 08:38AM
06:06AM Loading…
Jul-27-23 06:06AM
Jul-20-23 06:10AM
Jul-19-23 08:00AM
Jul-17-23 06:00AM
Jul-13-23 11:12PM
09:15AM
08:07AM
08:00AM
Jul-11-23 10:09AM
Jul-06-23 08:00AM
Jun-09-23 09:38AM
Apr-27-23 06:12AM
Apr-21-23 09:15AM
08:36AM
Apr-13-23 10:13PM
09:15AM
08:06AM
08:00AM
Apr-06-23 08:00AM
Mar-20-23 10:21AM
Feb-26-23 08:48AM
Feb-01-23 08:51AM
Jan-20-23 08:00AM
Jan-16-23 09:49AM
Jan-14-23 07:16AM
Jan-12-23 09:15AM
08:00AM
Jan-05-23 08:00AM
Dec-31-22 08:29AM
Nov-17-22 05:46AM
Nov-14-22 09:25AM
08:00AM
Nov-12-22 07:57AM
Nov-08-22 08:00AM
Nov-07-22 08:00AM
Oct-29-22 08:07AM
Oct-23-22 08:54AM
Oct-20-22 08:00AM
Oct-11-22 08:56AM
Sep-29-22 03:46AM
Sep-19-22 08:00AM
06:22AM
Aug-25-22 08:56AM
Aug-23-22 11:47AM
Aug-11-22 08:16AM
Jul-23-22 08:42AM
Jul-20-22 08:00AM
Jul-19-22 06:30AM
Jul-07-22 09:15AM
08:00AM
Jun-30-22 08:00AM
Jun-27-22 03:30AM
Jun-19-22 09:31AM
May-19-22 08:31AM
May-04-22 08:16AM
Apr-22-22 08:00AM
Apr-11-22 10:20AM
Apr-07-22 09:35AM
08:00AM
Mar-31-22 08:00AM
Mar-23-22 05:25PM
Mar-21-22 08:16AM
Feb-09-22 06:49AM
Jan-21-22 04:00PM
Jan-10-22 09:07AM
Jan-06-22 09:25AM
08:00AM
Jan-03-22 02:40AM
Dec-30-21 03:00PM
08:00AM
Northern Technologies International Corp. engages in the development and marketing of proprietary environmentally beneficial products and services. It operates through the Natur-Tec and Zerust segments. The Natur-Tec segment manufactures bio-degradable and bio-based plastics for industrial and consumer applications. The Zerust segment provides corrosion mitigation solutions and services to oil, gas, and chemical processing applications. The company was founded in 1970 and is headquartered in Circle Pines, MN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kemp Sarah E.DirectorApr 23 '24Buy15.701,27520,0185,760Apr 24 04:56 PM
von Falkenhausen KonstantinDirectorAug 28 '23Option Exercise7.358,00058,80015,200Aug 28 05:48 PM
Lee SunggyuDirectorAug 17 '23Option Exercise7.358,00058,8008,000Aug 21 04:07 PM
Calderon Nancy E.DirectorAug 14 '23Buy13.175006,5853,062Aug 14 04:23 PM
LYNCH G PATRICKPresident and CEOAug 08 '23Option Exercise7.3511,61085,334108,893Aug 10 04:44 PM
NIGON RICHARDDirectorJul 27 '23Sale12.171,84722,47833,600Jul 27 05:48 PM
NIGON RICHARDDirectorJul 26 '23Option Exercise7.3512,00088,20042,600Jul 27 05:48 PM
WOLSFELD MATTHEW CCFO and Corporate SecretaryJul 11 '23Option Exercise7.358,58263,078160,338Jul 12 05:17 PM
Last Close
May 01 04:00PM ET
16.30
Dollar change
+0.53
Percentage change
3.36
%
CELC Celcuity Inc daily Stock Chart
IndexRUT P/E- EPS (ttm)-2.70 Insider Own32.17% Shs Outstand25.51M Perf Week-3.78%
Market Cap496.33M Forward P/E- EPS next Y-3.23 Insider Trans-0.27% Shs Float20.66M Perf Month-17.01%
Income-63.78M PEG- EPS next Q-0.70 Inst Own42.34% Short Float8.94% Perf Quarter7.95%
Sales0.00M P/S- EPS this Y-5.51% Inst Trans5.92% Short Ratio8.03 Perf Half Y60.12%
Book/sh5.48 P/B2.97 EPS next Y-13.68% ROA-34.76% Short Interest1.85M Perf Year68.04%
Cash/sh5.93 P/C2.75 EPS next 5Y29.00% ROE-46.63% 52W Range8.39 - 22.19 Perf YTD11.87%
Dividend Est.- P/FCF- EPS past 5Y-29.52% ROI-36.03% 52W High-26.54% Beta0.87
Dividend TTM- Quick Ratio13.43 Sales past 5Y0.00% Gross Margin- 52W Low94.30% ATR (14)0.91
Dividend Ex-Date- Current Ratio13.43 EPS Y/Y TTM-3.24% Oper. Margin0.00% RSI (14)41.53 Volatility5.57% 4.84%
Employees55 Debt/Eq0.27 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price25.75
Option/ShortYes / Yes LT Debt/Eq0.27 EPS Q/Q4.98% Payout- Rel Volume1.54 Prev Close15.77
Sales Surprise- EPS Surprise10.75% Sales Q/Q- EarningsMar 27 AMC Avg Volume229.96K Price16.30
SMA20-8.92% SMA50-7.62% SMA20022.38% Trades Volume354,289 Change3.36%
Date Action Analyst Rating Change Price Target Change
Feb-22-24Initiated Stifel Buy $40
Dec-08-23Initiated H.C. Wainwright Buy $27
Oct-08-21Initiated Canaccord Genuity Buy $50
Sep-07-21Initiated Jefferies Buy $48
Jul-29-21Initiated Cowen Outperform
Jul-27-21Initiated Needham Buy $50
Jan-28-21Reiterated H.C. Wainwright Buy $14 → $18
Dec-24-20Reiterated H.C. Wainwright Buy $11 → $14
May-11-20Resumed Craig Hallum Buy
Nov-20-18Initiated H.C. Wainwright Buy $36
Apr-04-24 07:05AM
Apr-01-24 01:38PM
Mar-28-24 06:51AM
Mar-27-24 08:53PM
05:51PM
04:01PM Loading…
04:01PM
Mar-21-24 11:17AM
Mar-20-24 07:05AM
Mar-06-24 07:05AM
Feb-28-24 07:05AM
Feb-22-24 04:05PM
Feb-20-24 07:05AM
Dec-06-23 08:30AM
Dec-01-23 11:02AM
Nov-22-23 08:05AM
10:50AM Loading…
Nov-14-23 10:50AM
Nov-13-23 09:41PM
10:54AM
07:05AM
Nov-06-23 07:30AM
Nov-01-23 07:05AM
Oct-18-23 09:15AM
Sep-21-23 04:43PM
Sep-07-23 04:05PM
Sep-06-23 07:10PM
Aug-22-23 04:05PM
04:01PM
Aug-11-23 05:58AM
Aug-10-23 04:04PM
Aug-03-23 07:30AM
08:00AM Loading…
Jul-31-23 08:00AM
Jul-27-23 06:51AM
Jun-20-23 09:02AM
May-24-23 08:00AM
07:59AM
May-16-23 06:26AM
May-15-23 04:00PM
May-12-23 06:15AM
May-08-23 05:30PM
08:00AM
Apr-18-23 01:30PM
Apr-12-23 08:00AM
Mar-27-23 02:43AM
Mar-24-23 07:07AM
Mar-23-23 04:00PM
Mar-16-23 08:00AM
Mar-15-23 07:35PM
Mar-01-23 08:00AM
Feb-17-23 05:07AM
Feb-16-23 08:00AM
Dec-18-22 04:38AM
Dec-15-22 05:59AM
Dec-12-22 07:30AM
Dec-09-22 08:40AM
Dec-07-22 04:00PM
Nov-22-22 07:30AM
Nov-10-22 04:30PM
04:00PM
Nov-03-22 08:50AM
Sep-14-22 09:00AM
Aug-15-22 09:39AM
Aug-11-22 04:00PM
Aug-04-22 08:15AM
Aug-03-22 10:15AM
Jul-18-22 06:31PM
05:10PM
Jun-15-22 09:55AM
May-30-22 09:55AM
May-26-22 07:30AM
May-16-22 04:00PM
07:00AM
May-11-22 09:28AM
May-09-22 07:30AM
Apr-05-22 07:30AM
Mar-23-22 04:00PM
Mar-16-22 07:30AM
Mar-02-22 07:30AM
Mar-01-22 07:02AM
Jan-18-22 12:39PM
07:30AM
Dec-10-21 09:30AM
Dec-02-21 08:30AM
Nov-29-21 05:00PM
Nov-15-21 08:00AM
Nov-09-21 05:30PM
Nov-08-21 04:00PM
Oct-29-21 09:00AM
Oct-18-21 04:09PM
Oct-14-21 02:08PM
Sep-02-21 07:42AM
Aug-09-21 04:00PM
Aug-05-21 08:00AM
Aug-02-21 07:30AM
Jul-08-21 04:15PM
Jun-30-21 09:06AM
Jun-29-21 11:11AM
Jun-28-21 11:30PM
04:01PM
Jun-09-21 09:10AM
May-10-21 04:00PM
Celcuity, Inc. is cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. Its proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Buller Richard EDirectorApr 24 '24Sale17.063505,9717,731Apr 26 04:55 PM
Buller Richard EDirectorFeb 21 '24Sale14.153504,9528,081Feb 23 04:43 PM
Buller Richard EDirectorDec 20 '23Sale14.373505,0308,431Dec 22 04:09 PM
Dalvey DavidDirectorDec 15 '23Sale14.572,94042,847225,000Dec 18 04:43 PM
Dalvey DavidDirectorDec 14 '23Sale14.755,00073,752227,940Dec 18 04:43 PM
Dalvey DavidDirectorDec 13 '23Sale14.505,00072,500232,940Dec 14 06:05 PM
Dalvey DavidDirectorDec 12 '23Sale14.612,06030,089237,940Dec 14 06:05 PM
Dalvey DavidDirectorDec 08 '23Sale15.005,00075,000240,000Dec 11 04:19 PM
Dalvey DavidDirectorDec 07 '23Sale14.855,00074,250245,000Dec 11 04:19 PM
Furcht LeoDirectorNov 28 '23Option Exercise1.6025040010,500Nov 30 04:12 PM
Buller Richard EDirectorOct 25 '23Sale10.233503,5808,781Oct 27 04:30 PM
Buller Richard EDirectorAug 30 '23Sale9.283503,2489,131Sep 01 04:07 PM
Buller Richard EDirectorAug 23 '23Sale9.823002,9469,481Aug 25 05:09 PM
Buller Richard EDirectorJun 23 '23Sale11.793003,5379,781Jun 27 04:11 PM
Buller Richard EDirectorMay 23 '23Sale11.107583210,081May 25 04:23 PM
Furcht LeoDirectorMay 22 '23Buy10.3210,000103,18710,250May 24 04:32 PM
Buller Richard EDirectorMay 22 '23Sale10.501001,05010,156May 23 04:12 PM
Buller Richard EDirectorMay 19 '23Sale9.852502,46210,256May 23 04:12 PM